findmyKOL

Farhat Khairallah, MD

Basic profile

Tallahassee Memorial HealthCare

ORCIDNone on fileNPI
RegionTallahassee, FL · SoutheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Farhat Khairallah is a Cardiology physician affiliated with Tallahassee Memorial HealthCare. OpenAlex indexes 8 publications with 474 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
8publications

Distinct works indexed by OpenAlex.

474citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
111companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

111 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

111 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    52.2%
    Beta blocker29.6%
    Metoprolol Succinate69%Metoprolol Tartrate11%Carvedilol8%Sotalol8%Propranolol Hcl2%Atenolol1%Nebivolol Hcl1%
    Part D<11 patients
    Antiarrhythmic7%
    Amiodarone Hcl63%Dofetilide26%Flecainide Acetate11%
    Part D88 patients

    + 13 more classes in this area

  • Blood & clotting

    42.4%
    Factor Xa inhibitor38%
    Eliquis83%Xarelto17%
    Part D375 patients
    P2Y12 inhibitor1.8%
    Clopidogrel100%
    Part D42 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    3.4%
    Proton pump inhibitor1.6%
    Pantoprazole Sodium100%
    Part D53 patients
    Potassium supplement1.4%
    Potassium Chloride100%
    Part D30 patients

    + 1 more class in this area

Where care is delivered (Part B)26.8% facility · 73.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”